Saturday, August 18, 2018
Company News: Page (1) of 1 - 02/12/18 Email this story to a friend. email article Print this page (Article printing at page facebook
The Charles E. Holman Morgellons Disease Foundation (CEHMDF) is Kicking Off The Month of February With a Bang
(February 12, 2018)
The Charles E. Holman Morgellons Disease Foundation (CEHMDF) is Kicking Off The Month of February With a Bang

For the first time ever, the CEHMDF has officially designated the month of February as Morgellons Awareness Month. February was chosen in celebration of Charles E. Holman, founder of the organization, whose birthday was ?February 12th.

On February 1st, the documentary film, Skin Deep: The Battle Over Morgellons launched their Kickstarter campaign. The foundation president, Cindy Casey, and many other members of the CEHMDF have an active role in this film. Director Pi Ware and his team are committed to raising awareness and creating empathy by sharing the stories of Morgellons patients, the physicians who treat them, and the science behind the disease. “Fortunately," states Pi Ware, the film's director, "we have filmed 80% of our footage already, which means the challenges of finding the characters and story are already behind us. We just need this funding to get us to the editorial finish line.Our goals with Skin Deep are to show the reality of this devastating disease and to inspire both hope and government funding for research." In honor of Morgellons Awareness Month, Skin Deep has released a 3 minute trailer and launched their the Kickstarter campaign at:

In addition, the Facebook page for Skin Deep: The Battle Over Morgellons has created a new Morgellons Awareness Month Facebook frame for profile photos at

The CEHMDF holds an annual conference in Austin, TX and February 1st marked the opening day of early bird registration for the 11th Annual Medical-Scientific Conference on Morgellons to be held ?on April 14-15, 2018 at the Wyndham Garden Hotel in Austin. This conference brings physicians, scientists, nurses, patients and their families together for 2 days of presentations. The very latest in research and treatment of Morgellons will be presented. An evening reception on Saturday ensures attendees ample opportunity to visit with speakers.

"We're excited to welcome new speakers this year," states Cindy Casey-Holman, RN, Director of the foundation. "Morgellons research from Mt. Allison University in New Brunswick will be presented this year for the very first time!" Conference details including list of speakers, registration and hotel information are available on the foundation's website

About The Charles E. Holman Morgellons Disease Foundation
The Charles E. Holman Morgellons Disease Foundation, based in ?Austin, TX, is a 501(c) (3) nonprofit organization committed to advocacy and philanthropy in the battle against Morgellons. Director, Cindy Casey-Holman, RN, leads the foundation, named for her husband, Charles E. Holman, a pioneer in the fight against MD.

The CEHMDF is the recognized authority and primary funding source for Morgellons Disease medical-scientific research. To learn more about Morgellons Disease go to

Read the full story at

Page: 1

Related Keywords:
Related Sites: Digital Producer ,   Presentation Master ,   Oceania ,   DMN Newswire ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: DMN Newsletter ,   CMN Newsletter ,   KNews Newsletter ,   DMNForums ,   Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
  • Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines